Inventor · disambiguated record
Regis Cebe
Also filed as: CEBE REGIS
6 granted patents·11 pending applications·2 citations·filing 2016–2025
70Inventor score
Top patents by PatentIndex Score
17 records- 0185US2025179156A1Angiopoietin-like 4 antibodies and methods of useNOVARTIS AG·Filed 2024·Application pending·0 cites
- 0284US12221481B2CD19 binding molecules and uses thereofNOVARTIS AG·Filed 2020·Granted Feb 11, 2025·2 cites·13 claims
- 0377US2023416407A1Fgf21 mimetic antibodies and uses thereofNOVARTIS AG·Filed 2023·Application pending·0 cites
- 0476US2022213181A1Angiopoietin-like 4 antibodies and methods of useNOVARTIS AG·Filed 2022·Application pending·0 cites
- 0575US2025388698A1Fgf21 mimetic antibodies and uses thereofNOVARTIS AG·Filed 2025·Application pending·0 cites
- 0670US2025223359A1Cd19 binding molecules and uses thereofNOVARTIS AG·Filed 2024·Application pending·0 cites
- 0769US11692046B2FGF21 mimetic antibodies and uses thereofNOVARTIS AG·Filed 2020·Granted Jul 4, 2023·0 cites·13 claims
- 0863US11802152B2Methods of treating FGF21-associated disordersNOVARTIS AG·Filed 2021·Granted Oct 31, 2023·0 cites·7 claims
- 0959US10899844B2FGF21 mimetic antibodies and uses thereofNOVARTIS AG·Filed 2018·Granted Jan 26, 2021·0 cites·10 claims
- 1057US2023357381A1Multispecific antibodies targeting il-13 and il-18NOVARTIS AG·Filed 2023·Application pending·0 cites
- 1156US2025000973A1Methods of making chimeric antigen receptor-expressing cellsNOVARTIS AG·Filed 2022·Application pending·0 cites
- 1255US11685776B2Engineered heterodimeric proteinsNOVARTIS AG·Filed 2018·Granted Jun 27, 2023·0 cites·16 claims
- 1353US2025215081A1Anti-cd19 agent and b cell targeting agent combination therapy for treating b cell malignanciesNOVARTIS AG·Filed 2021·Application pending·0 cites
- 1450US2024025993A1Cd19 binding molecules and uses thereofNOVARTIS AG·Filed 2021·Application pending·0 cites
- 1549US11236159B2Methods of treating FGF21-associated disordersNOVARTIS AG·Filed 2016·Granted Feb 1, 2022·0 cites·8 claims
- 1649US2023302155A1Compositions and methods for in vivo generation of car expressing cellsNOVARTIS AG·Filed 2021·Application pending·0 cites
- 1747US2023256017A1Methods of making chimeric antigen receptor-expressing cellsBROGDON JENNIFER·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Regis Cebe files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →